258 related articles for article (PubMed ID: 21828189)
1. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
[TBL] [Abstract][Full Text] [Related]
2. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
[TBL] [Abstract][Full Text] [Related]
3. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.
Bhooshan N; Giger ML; Jansen SA; Li H; Lan L; Newstead GM
Radiology; 2010 Mar; 254(3):680-90. PubMed ID: 20123903
[TBL] [Abstract][Full Text] [Related]
4. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.
Parsian S; Rahbar H; Allison KH; Demartini WB; Olson ML; Lehman CD; Partridge SC
Radiology; 2012 Dec; 265(3):696-706. PubMed ID: 23033500
[TBL] [Abstract][Full Text] [Related]
5. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
6. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
[No Abstract] [Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM
Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.
Li X; Priest RA; Woodward WJ; Tagge IJ; Siddiqui F; Huang W; Rooney WD; Beer TM; Garzotto MG; Springer CS
Magn Reson Med; 2013 Jan; 69(1):171-8. PubMed ID: 22457233
[TBL] [Abstract][Full Text] [Related]
13. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
Yankeelov TE; Rooney WD; Huang W; Dyke JP; Li X; Tudorica A; Lee JH; Koutcher JA; Springer CS
NMR Biomed; 2005 May; 18(3):173-85. PubMed ID: 15578708
[TBL] [Abstract][Full Text] [Related]
14. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
Amarosa AR; McKellop J; Klautau Leite AP; Moccaldi M; Clendenen TV; Babb JS; Zeleniuch-Jacquotte A; Moy L; Kim S
Radiology; 2013 Aug; 268(2):356-65. PubMed ID: 23657893
[TBL] [Abstract][Full Text] [Related]
19. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
20. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
